-
New atypical epidemiological profile of parvovirus B19 revealed by molecular screening of blood donations, France, winter 2023/24
- Marlène Guillet1 , Ariane Bas2 , Marjorie Lacoste3 , Céline Ricard4 , Catherine Visse5 , Valérie Barlet2 , Lucile Malard6 , Sophie Le Cam6 , Pascal Morel6 , Xavier de Lamballerie7 , Syria Laperche6 , Pierre Gallian6,7
-
View Affiliations Hide AffiliationsAffiliations: 1 Etablissement Français du Sang Centre Pays de Loire, Nantes, France 2 Etablissement Français du Sang Auvergne Rhône Alpes, Lyon Décines, France 3 Etablissement Français du Sang Occitanie, Toulouse, France 4 Etablissement Français du Sang Hauts de France-Normandie, Loos, France 5 LFB – Biomédicaments, Control Laboratories, Courtaboeuf Cedex, France 6 Etablissement Français du Sang, La Plaine Saint-Denis, France. 7 Unité des Virus Émergents (UVE: Aix-Marseille Univ-Corsica Univ-IRD 190-Inserm 1207-IRBA), Marseille, FrancePierre Gallianpierre.gallian efs.sante.fr
-
View Citation Hide Citation
Citation style for this article: Guillet Marlène, Bas Ariane, Lacoste Marjorie, Ricard Céline, Visse Catherine, Barlet Valérie, Malard Lucile, Le Cam Sophie, Morel Pascal, de Lamballerie Xavier, Laperche Syria, Gallian Pierre. New atypical epidemiological profile of parvovirus B19 revealed by molecular screening of blood donations, France, winter 2023/24. Euro Surveill. 2024;29(21):pii=2400253. https://doi.org/10.2807/1560-7917.ES.2024.29.21.2400253 Received: 25 Apr 2024; Accepted: 21 May 2024
- Previous Article
- Table of Contents
- Next Article
Abstract
In France, blood donations are tested in pools of 96 samples for parvovirus B19 (B19V) DNA to discard plasma for fractionation when it contains high viral loads. Between January 2015 and March 2024, B19V-positive donations decreased during the COVID-19 pandemic, followed by a strong rebound in 2023 and unusually high circulation during winter 2023/24 (ca 10 times higher December 2023–March 2024 vs the pre-pandemic period). Variations over time are probably related to measures implemented to limit SARS-CoV-2 spread.
Article metrics loading...
Full text loading...
References
-
Zaaijer HL, Koppelman MH, Farrington CP. Parvovirus B19 viraemia in Dutch blood donors. Epidemiol Infect. 2004;132(6):1161-6. https://doi.org/10.1017/S0950268804002730 PMID: 15635975
-
European Centre for Disease Prevention and Control (ECDC). Communicable disease threats report, 14-20 April 2024, week 16. Stockholm: ECDC; 2024. Available from: https://www.ecdc.europa.eu/en/publications-data/communicable-disease-threats-report-14-20-april-2024-week-16
-
Candotti D, Etiz N, Parsyan A, Allain JP. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol. 2004;78(22):12169-78. https://doi.org/10.1128/JVI.78.22.12169-12178.2004 PMID: 15507603
-
Matsukura H, Shibata S, Tani Y, Shibata H, Furuta RA. Persistent infection by human parvovirus B19 in qualified blood donors. Transfusion. 2008;48(5):1036-7. https://doi.org/10.1111/j.1537-2995.2008.01704.x PMID: 18454740
-
Sun P, Jiang P, Liu Q, Zhang R, Wang Z, Cao H, et al. Parvovirus B19 DNA and antibodies in Chinese plasma donors, plasma pools and plasma derivatives. PeerJ. 2023;11:e15698. https://doi.org/10.7717/peerj.15698 PMID: 37554334
-
Williams S, Ratcliff J, Nguyen D, Simmonds P, Harvala H, International Survey Group. Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England. Transfus Med. 2022;32(5):402-9. https://doi.org/10.1111/tme.12893 PMID: 35751630
-
Gowland P, Fontana S, Stolz M, Andina N, Niederhauser C. Parvovirus B19 passive transmission by transfusion of intercept® blood system-treated platelet concentrate. Transfus Med Hemother. 2016;43(3):198-202. https://doi.org/10.1159/000445195 PMID: 27403092
-
Azzi A, Morfini M, Mannucci PM. The transfusion-associated transmission of parvovirus B19. Transfus Med Rev. 1999;13(3):194-204. https://doi.org/10.1016/S0887-7963(99)80033-9 PMID: 10425692
-
Marano G, Vaglio S, Pupella S, Facco G, Calizzani G, Candura F, et al. Human parvovirus B19 and blood product safety: a tale of twenty years of improvements. Blood Transfus. 2015;13(2):184-96. PMID: 25849894
-
Satake M, Hoshi Y, Taira R, Momose SY, Hino S, Tadokoro K. Symptomatic parvovirus B19 infection caused by blood component transfusion. Transfusion. 2011;51(9):1887-95. https://doi.org/10.1111/j.1537-2995.2010.03047.x PMID: 21332725
-
Human anti-D immunoglobulin for Intravenous Administration. In: European Pharmacopoeia. 10th ed. Strasbourg: The European Pharmacopoeia Commission; 2020.Available from: https://www.edqm.eu/en/-/shutdown-of-european-pharmacopoeia-10th-edition
-
Nawrocki J, Olin K, Holdrege MC, Hartsell J, Meyers L, Cox C, et al. The effects of social distancing policies on non-SARS-CoV-2 respiratory pathogens. Open Forum Infect Dis. 2021;8(7):ofab133. https://doi.org/10.1093/ofid/ofab133 PMID: 34322558
-
Launay T, Souty C, Vilcu AM, Turbelin C, Blanchon T, Guerrisi C, et al. Common communicable diseases in the general population in France during the COVID-19 pandemic. PLoS One. 2021;16(10):e0258391. https://doi.org/10.1371/journal.pone.0258391 PMID: 34634090
-
Sanz-Muñoz I, Tamames-Gómez S, Castrodeza-Sanz J, Eiros-Bouza JM, de Lejarazu-Leonardo RO. Social distancing, lockdown and the wide use of mask; a magic solution or a double-edged sword for respiratory viruses epidemiology? Vaccines (Basel). 2021;9(6):595. https://doi.org/10.3390/vaccines9060595 PMID: 34205119
-
Bernard-Stoecklin S, Équipes de surveillance de la grippe. Surveillance de la grippe en France, saison 2022-2023. [Influenza surveillance in France, 2022-2023 season. Bull Épidémiol Hebd. 2023;(19):382-97. French. Available from: http://beh.santepubliquefrance.fr/beh/2023/19/2023_19_1.html
-
Santé Publique France. Bronchiolite. Bilan de la surveillance 2022-2023. [Bronchiolitis. Surveillance report 2022-2023]. Saint-Maurice: Santé Publique France; 2023. French. Available from: https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/bronchiolite/documents/bulletin-national/bulletin-epidemiologique-bronchiolite.-bilan-de-la-surveillance-2022-2023
-
Molenaar-de Backer MW, Hogema BM, Koppelman MH, van de Laar TJ, Slot E, Zaaijer HL. Lower incidence of parvovirus-B19 infections in Dutch blood donors during SARS-CoV-2 Pandemic. Microbiol Spectr. 2021;9(2):e0025321. https://doi.org/10.1128/Spectrum.00253-21 PMID: 34523999
-
Sauleda S, Piron M, Bes M, Martinez-Llonch N, Puig L. Changes in parvovirus B19 positivity rates in plasma units for fractionation: An unexpected effect of non-pharmaceutical interventions against COVID-19? Vox Sang. 2022;117(4):626-7. https://doi.org/10.1111/vox.13229 PMID: 34877666
-
Drews SJ, Charlton C, O’Brien SF, Burugu S, Denomme GA. Decreasing parvovirus B19 and hepatitis A nucleic acid test positivity rates in Canadian plasma donors following the initiation of COVID-19 restriction in March 2020. Vox Sang. 2024;vox.13616. https://doi.org/10.1111/vox.13616 PMID: 38482941
-
Patalon T, Saciuk Y, Trotzky D, Pachys G, Ben-Tov A, Segal Y, et al. An outbreak of parvovirus B19 in Israel. Viruses. 2023;15(11):2261. https://doi.org/10.3390/v15112261 PMID: 38005937
-
Fourgeaud J, Allali S, Toubiana J, Pinhas Y, Frange P, Leruez-Ville M, et al. Post-COVID-19 pandemic outbreak of severe parvovirus B19 primary infections in Paris, France: 10-year interrupted time-series analysis (2012-2023). J Clin Virol. 2023;167:105576. https://doi.org/10.1016/j.jcv.2023.105576 PMID: 37633184
-
Semaille C (directrice de publication). Epidémie d’infections à Parvovirus B-19. [Epidemic of parvovirus B-19 infections]. Saint-Maurice: Santé publique France; 2024. French. Available from: https://www.santepubliquefrance.fr/content/download/620047/4261122?version=2#:~:text=Une%20%C3%A9pid%C3%A9mie%20d'infections%20%C3%A0,atteint%20au%20mois%20de%20mars
Data & Media loading...